Solara’s Cuddalore facility completes EU GMP Inspection

13 Feb 2023 Evaluate

Solara Active Pharma Sciences (Solara) has successfully completed EU GMP Inspection, carried out jointly by the State Institute for Drug Control (SUKL), Ministry of Health of the Czech Republic and National Authority of Medicines and Health Products (INFARMED), Portugal from February 07, 2023 to February 9, 2023, at the multi-product manufacturing facility at Cuddalore.

At the end of the inspection, it is concluded that the Quality Systems followed at Cuddalore site is Compliant to the EU GMP Standards. This Cuddalore facility has also successfully completed the inspection carried out by the World Health Organization (WHO) between January 23, 2023 to January 26, 2023.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.